Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2021-11-10 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no textual content or substantive information. The true document length is only 171 characters, which is extremely short and contains no report data or announcements. Given the lack of content, this cannot be classified as a report or detailed filing. It is most consistent with a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2021-11-10 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text contains only placeholders for images and no textual content or substantive information. The true document length is only 171 characters, which is extremely short and contains no report data or announcements. It does not contain any financial data, regulatory references, or report titles. Given the lack of content, this document cannot be classified as a report or announcement type and defaults to the fallback category for miscellaneous filings.
2021-11-10 English
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/11/2021 ,inter alia, to consider and approve This is with reference to our earlier ....
Regulatory Filings
2021-11-10 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document text is extremely short (582 characters) and consists mainly of addresses to stock exchanges (BSE and NSE) with scrip codes and symbols. There is no substantive financial data, report content, or detailed information. It appears to be a brief communication or notice rather than a full report or detailed filing. Given the brevity and nature, it is likely a Regulatory Filing (RNS) as a general announcement or compliance communication without detailed financial or report content.
2021-11-01 English
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve Notice is hereby given pursuant to ....
Regulatory Filings
2021-11-01 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Wanbury Limited dated 20th October 2021, reporting the outcome of a Board Meeting. It includes approval of standalone and consolidated unaudited financial results for the first quarter ended 30th June 2021, details of share allotment under an employee stock option plan, and related disclosures as per SEBI regulations. The document contains substantive financial data (unaudited financial results) and detailed disclosures about share allotment and employee stock options. It is not merely an announcement of a report being published but includes actual financial results and related information. Therefore, this document fits the definition of an Interim / Quarterly Report (IR), as it covers a period shorter than a full fiscal year and contains actual financial statements and analysis.
2021-10-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.